Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

ABSTRACT: Panobinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well panobinostat works in treating patients with relapsed or refractory non-Hodgkin lymphoma

DISEASE(S): Recurrent Grade 3 Follicular Lymphoma,Lymphoma, Large B-cell, Diffuse,Extranodal Marginal Zone B-cell Lymphoma Of Mucosa-associated Lymphoid Tissue,Lymphoproliferative Disorders,Mycoses,Angioimmunoblastic T-cell Lymphoma,Recurrent Adult Lymphoblastic Lymphoma,Small Intestine Lymphoma,Recurrent Grade 1 Follicular Lymphoma,Sezary Syndrome,Adult Nasal Type Extranodal Nk/t-cell Lymphoma,Splenic Marginal Zone Lymphoma,Lymphoma, Large-cell, Anaplastic,Lymphoma, Mantle-cell,Mycosis Fungoides,Leukemia-lymphoma, Adult T-cell,Lymphoma, T-cell,Recurrent Adult Burkitt Lymphoma,Leukemia, T-cell,Hepatosplenic T-cell Lymphoma,Lymphoma, T-cell, Peripheral,Lymphoma, Extranodal Nk-t-cell,Immunoblastic Lymphadenopathy,Precursor Cell Lymphoblastic Leukemia-lymphoma,Lymphoma, B-cell, Marginal Zone,Burkitt Lymphoma,Lymphoma,Recurrent Mycosis Fungoides/sezary Syndrome,Post-transplant Lymphoproliferative Disorder,Anaplastic Large Cell Lymphoma,Nodal Marginal Zone B-cell Lymphoma,Recurrent Small Lymphocytic Lymphoma,Recurrent Grade 2 Follicular Lymphoma,Lymphoma, Follicular,Waldenstrom Macroglobulinemia,Peripheral T-cell Lymphoma,Recurrent Adult T-cell Leukemia/lymphoma,Lymphoma, Non-hodgkin,Recurrent Adult Diffuse Large Cell Lymphoma,Lymphoma, B-cell,Leukemia, Lymphocytic, Chronic, B-cell,Recurrent Mantle Cell Lymphoma

PROVIDER: 2099626 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR